Gain Therapeutics
GANX
GANX
19 hedge funds and large institutions have $9.77M invested in Gain Therapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
82% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 11
Holders
19
Holding in Top 10
–
Calls
$18K
Puts
–
Top Buyers
| 1 | +$7.38M | |
| 2 | +$157K | |
| 3 | +$92.5K | |
| 4 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
+$27.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.54K |
Top Sellers
| 1 | -$775K | |
| 2 | -$576K | |
| 3 | -$422K | |
| 4 |
CCC
Cable Car Capital
San Francisco,
California
|
-$186K |
| 5 |
Renaissance Technologies
New York
|
-$116K |